Avb500, A Receptor Tyrosine Kinase Axl Inhibitor, Has Improved Therapeutic Efficacy In Combination With Bevacizumab Compared To Bevacizumab Alone In Uterine Serous Cancer Mouse Model

M.D. Toboni, J.I. Tankou,M.M. Mullen, A. Oplt, H. Noia,P. Cannon,L.M. Kuroki,A.R. Hagemann,C.K. McCourt,P.H. Thaker, D.G. Mutch,M.A. Powell,K.C. Fuh

GYNECOLOGIC ONCOLOGY(2020)

引用 0|浏览27
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要